Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients

Overview of attention for article published in BMC Neurology, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 25 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Preventing stroke-related deaths and easing NHS burden with pharmacogenetic testing

Health Tech World, 28 Oct 2022

Ahead of World Stroke Day, David Budd, CEO of genedrive plc, underscores the growing role of pharmacogenetics in personalised…

Preventing stroke-related deaths with pharmacogenetic testing

European Pharmaceutical Manufacturer, 28 Oct 2022

Ahead of World Stroke Day, David Budd, CEO of genedrive plc, underscores the growing role of pharmacogenetics in personalised…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.